Literature DB >> 12935800

The role of uninjured nerve in spinal nerve ligated rats points to an improved animal model of neuropathic pain.

Doo H Lee1, Smriti Iyengar, David Lodge.   

Abstract

L5 and L6 spinal nerve ligation (SNL) in rats leads to behavioral signs of neuropathic pain including mechanical allodynia. The purposes of this study were to investigate the role of the intact L4 spinal nerve in the development of mechanical allodynia following L5 and L6 SNL and, as a result, to develop a modified model of neuropathic pain. As a first set of experiments, in addition to tight ligation of the left L5 and L6 spinal nerves, the intact L4 spinal nerve was manipulated either (1) by gentle repeated stretching of the L4 spinal nerve immediately after L5 and L6 SNL or (2) by intermittent mechanical stimulation to the ipsilateral paw during the first week after SNL. Tactile sensitivity was measured by determining the foot withdrawal threshold before and after SNL. Mild irritation of L4 spinal nerve and application of mechanical stimuli to the ipsilateral paw significantly increased the development of mechanical allodynia after SNL. In a second set of experiments, SNL was produced by tightly ligating only the left L5 spinal nerve with or without a loop of 5-0 chromic gut placed loosely around the L4 spinal nerve. This additional L4 loop significantly increased long-lasting tactile sensitivity compared to L5 SNL alone. These results suggest that afferent activity of the intact L4 spinal nerve aids in the development of mechanical allodynia in the SNL model of neuropathic pain. The addition of a chromic gut loop around the intact L4 spinal nerve can augment the development of mechanical allodynia following SNL of L5. We propose this latter as a useful and practical animal model of neuropathic pain.

Entities:  

Mesh:

Year:  2003        PMID: 12935800     DOI: 10.1016/S1090-3801(03)00019-3

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  8 in total

1.  Efficacy of improgan, a non-opioid analgesic, in neuropathic pain.

Authors:  Phillip J Albrecht; Julia W Nalwalk; Lindsay B Hough
Journal:  Brain Res       Date:  2011-10-08       Impact factor: 3.252

2.  Antinociceptive activity of CC44, a biotinylated improgan congener.

Authors:  Paul Hoerbelt; Julia W Nalwalk; James G Phillips; Mark P Wentland; Zhixing Shan; Lindsay B Hough
Journal:  Eur J Pharmacol       Date:  2013-07-05       Impact factor: 4.432

3.  At-level neuropathic pain is induced by lumbosacral ventral root avulsion injury and ameliorated by root reimplantation into the spinal cord.

Authors:  A J Bigbee; T X Hoang; L A Havton
Journal:  Exp Neurol       Date:  2006-12-21       Impact factor: 5.330

4.  Chemical and mechanical nerve root insults induce differential behavioral sensitivity and glial activation that are enhanced in combination.

Authors:  Sarah M Rothman; Beth A Winkelstein
Journal:  Brain Res       Date:  2007-09-06       Impact factor: 3.252

5.  Plasticity in intact A delta- and C-fibers contributes to cold hypersensitivity in neuropathic rats.

Authors:  G Ji; S Zhou; M Y Kochukov; K N Westlund; S M Carlton
Journal:  Neuroscience       Date:  2007-09-19       Impact factor: 3.590

6.  Governing role of primary afferent drive in increased excitation of spinal nociceptive neurons in a model of sciatic neuropathy.

Authors:  Graham M Pitcher; James L Henry
Journal:  Exp Neurol       Date:  2008-08-16       Impact factor: 5.330

7.  Spontaneous pain, both neuropathic and inflammatory, is related to frequency of spontaneous firing in intact C-fiber nociceptors.

Authors:  Laiche Djouhri; Stella Koutsikou; Xin Fang; Simon McMullan; Sally N Lawson
Journal:  J Neurosci       Date:  2006-01-25       Impact factor: 6.167

8.  Spatiotemporal dynamics of re-innervation and hyperinnervation patterns by uninjured CGRP fibers in the rat foot sole epidermis after nerve injury.

Authors:  Liron S Duraku; Mehdi Hossaini; Sieske Hoendervangers; Lukas L Falke; Shoista Kambiz; Vivek C Mudera; Joan C Holstege; Erik T Walbeehm; Tom J H Ruigrok
Journal:  Mol Pain       Date:  2012-08-30       Impact factor: 3.395

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.